Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
Ergang Wang, Kun Xiang, Yun Zhang, et al.
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 263-276
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling, Callum Beach, Anderson J. Ryan
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108631-108631
Open Access | Times Cited: 19
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 19
Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
Lichan Chen, Xiafei Wei, Dayong Gu, et al.
Cancer Letters (2023) Vol. 555, pp. 216048-216048
Closed Access | Times Cited: 33
Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance
Shengwei Jiang, Tingwei Deng, Huan Cheng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 31
The role of organoids in cancer research
Zhen Fang, Peijuan Li, Fengying Du, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Experimental Murine Models for Colorectal Cancer Research
Íris Neto, João Rocha, Maria Manuela Gaspar, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2570-2570
Open Access | Times Cited: 17
Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
Evangelia Sereti, Irida Papapostolou, Konstantinos Dimas
Biomedicines (2023) Vol. 11, Iss. 3, pp. 890-890
Open Access | Times Cited: 15
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 4
Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges
Diletta Piana, Federica Iavarone, Elisa De Paolis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8830-8830
Open Access | Times Cited: 4
3D tumor cultures for drug resistance and screening development in clinical applications
Zheng Peng, Xiaolan Lv, Hao Sun, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
From organoids to organoids-on-a-chip: Current applications and challenges in biomedical research
Kailun Liu, Xiaowei Chen, Zhen Fan, et al.
Chinese Medical Journal (2025)
Open Access
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Martina Taglieri, Linda Di Gregorio, Serena Matis, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 457-457
Open Access
Breast cancer: Current status of preclinical research
Manisha Sahariah, Purabi Das, Harbinder Sharma
Elsevier eBooks (2025), pp. 177-204
Closed Access
Long non-coding RNA LRTOR drives osimertinib resistance in non-small cell lung cancer by boosting YAP positive feedback loop
Zhimin Miao, Sha Zhou, Jianzhong He, et al.
Drug Resistance Updates (2025), pp. 101245-101245
Open Access
The future of cancer therapy: exploring the potential of patient-derived organoids in drug development
Çığır Biray Avcı, Bakiye Göker Bağca, Behrouz Shademan, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
Zhenjie Yang, Jun Yu, Chi Chun Wong
Cells (2024) Vol. 13, Iss. 16, pp. 1312-1312
Open Access | Times Cited: 2
Mini-organs with big impact: Organoids in liver cancer studies
Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 5, pp. 677-688
Open Access | Times Cited: 5
Expediting the development of robust 5-FU-resistant colorectal cancer models using innovative combined in vivo and in vitro strategies
Ming Shao, Yunran Gao, Xiling Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117576-117576
Open Access | Times Cited: 1
Closing Editorial: Colorectal Cancer—A Molecular Genetics Perspective
Ehsan Gharib
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12604-12604
Open Access | Times Cited: 1
The use of patient-derived xenografts and patient-derived organoids in the search for new therapeutic regimens for pancreatic carcinoma. A review
Emin Gayibov, Tomáš Sychra, Alžběta Spálenková, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117750-117750
Closed Access | Times Cited: 1
Esophageal organoids: applications and future prospects
Hongyuan Liu, Xianli Wang
Journal of Molecular Medicine (2023) Vol. 101, Iss. 8, pp. 931-945
Closed Access | Times Cited: 3
Murine Xenograft Models as Preclinical Tools in Endometrial Cancer Research
Merve Yildiz, Andrea Romano, Sofia Xanthoulea
Cancers (2024) Vol. 16, Iss. 23, pp. 3994-3994
Open Access
A precision oncology-focused deep learning framework for personalized selection of cancer therapy
Casey Sederman, Chieh‐Hsiang Yang, Emilio Cortes-Sanchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Current views on in vivo models for breast cancer research and related drug development
Tiago Ferreira, Tiago Azevedo, Jéssica Silva, et al.
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 189-207
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top